Sickle cell disease: A review

Immunohematology

Volumn 25, Issue 2, 2009, Pages 67-74

  Roseff, Susan D ^a,b  

^a Molecular Pathology Division   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE CHEST SYNDROME; ALLOIMMUNIZATION; BLOOD TRANSFUSION; CHILD; CLINICAL FEATURE; CYTAPHERESIS; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ERYTHROCYTE; HEMOGLOBINOPATHY; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERHEMOLYTIC SYNDROME; IMMUNOPATHOLOGY; INFECTION; IRON OVERLOAD; LABORATORY TEST; LEUKAPHERESIS; NEWBORN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREOPERATIVE CARE; PRIAPISM; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SICKLE CELL; SICKLE CELL ANEMIA; SPLEEN DISEASE; STROKE; TREATMENT INDICATION;

ANEMIA, SICKLE CELL; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES, ABNORMAL; HEMOGLOBINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; PRACTICE GUIDELINES AS TOPIC; STEROIDS;

EID: 70349571753     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850-858
2. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-1621 (Pubitemid 20171584)
3. Elghetany MT, Banki K. Erythrocytic disorders. In: McPherson RA, Pincus MR, eds. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia, PA: Saunders Elsevier, 2007:504-544
4. Ogedegbe HO. Sickle cell disease: an overview. Lab Med 2002;33:515-543
5. Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin Hematol 2001;38:5-13. (Pubitemid 32110267)
6. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-1599 (Pubitemid 16118215)
7. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Cooperative study of sickle cell disease. Pediatrics 1989;84:500-508 (Pubitemid 19216350)
8. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood 1995;86:776-783
9. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease - life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644 (Pubitemid 124005049)
10. Telen MJ. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematol Am Soc Hematol Educ Program 2007;84-90.
11. Kupyers FA. Membrane lipid alterations in hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2007;68-73.
12. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998;91:4216-4223 (Pubitemid 28261985)
13. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14:191-197 (Pubitemid 46597602)
14. Adams RJ, McKie VC, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-610
15. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11. (Pubitemid 28304491)
16. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110-129 (Pubitemid 28085558)
17. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-1865
18. Sakhalkar VS, Rao SP, Weedon J, Miller ST. Elevated plasma sVCAM-1 levels in children with sickle cell disease: impact of chronic transfusion therapy. Am J Hematol 2004;76:57-60. (Pubitemid 38579539)
19. 2. Br J Haematol 2007;136:343-344 (Pubitemid 46020766)
20. Claster S, Vichinsky EP. Managing sickle cell disease. BMJ 2003;327:1151-1155
21. Platt O, Thorington B, Brambilla D, et al. Pain in sickle cell disease. N Engl J Med 1991;325:11-16.
22. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-1651
23. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322
24. Ware RE, Zimmerman SA, Shultz WH. Hydroxyurea as an alternative to blood transfusion for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999;94:3022-3026
25. Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007;110:1043-1047 (Pubitemid 47267446)
26. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-2143 (Pubitemid 36302049)
27. Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007;110:2749-2756 (Pubitemid 47523201)
28. Woodard P, Jeng M, Handgretinger R, et al. Summary of symposium: the future of stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 2002;34:512-517 (Pubitemid 36004534)
29. Josephson CD, Lu LL, Killyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007;21:118-133 (Pubitemid 46482993)
30. Koshy M, Burd L, Wallace D, et al. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. N Engl J Med 1988;319:1447-1452
31. Rackoff WR, Ohene-Frempong K, Month S, et al. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 1992;120:882-885
32. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-213
33. Buck J, Casbard A, Llewelyn C, Johnson T, Davies SC, Williamson LM. Preoperative transfusion in sickle cell disease: a survey of practice in England. Eur J Haematol 2005;75:14-21. (Pubitemid 40873956)
34. Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med 2000;342:1904-1907 (Pubitemid 30419057)
35. Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769-2778
36. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-1092 (Pubitemid 32848083)
37. Osby M, Shulman IA. Phenotype matching of donor red blood cells units for non alloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190-193 (Pubitemid 40204796)
38. Afenyi-Annan A, Brecher ME. Pre-transfusion phenotype matching for sickle cell disease patients. Transfusion 2005;44:619-620
39. Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 1994;34:558-560
40. Hillyer KL, Hare VW, Josephson CD, et al. Partners for life: the transfused program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematology 2006;22:108-111
41. Brecher ME. Technical Manual. 15th ed. Bethesda, MD: American Association of Blood Banks, 2005.
42. King KE, Shirey RS, Lenkiewica MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997;37:376-381
43. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-392 (Pubitemid 27193551)
44. Win N, Yeghen T, Needs, et al. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004;9:433-436 (Pubitemid 40123596)
45. Porter JB. Concepts and goals in the management of transfusional iron overload. Am J Hematol 2007;82:1136-1139
46. Blumberg N, Heal JM, Gettings KF. Leukoreduction of red cell transfusion is associated with a decreased incidence of red cell alloimmunization. Transfusion 2003;43:945-952
47. Mayo Clinic. Sickle cell anemia. Available at: http://www.mayoclinic.com/ health/sickle-cell-anemia/DS00324. Accessed July 20, 2009.
48. Sickle Cell Disease Association of America, Inc. Available at: http://www.sicklecelldisease.org/. Accessed July 20, 2009.
49. March of Dimes. Available at: http://www.marchofdimes.com/. Accessed July 20, 2009.
50. Lab Tests On Line. Available at: http://www.labtestsonline.org/. Accessed July 20, 2009.